Posts tagged as: Infectious Diseases

Sanofi Pasteur Singapore launches first quadrivalent conjugate meningococcal vaccine

Sanofi Pasteur recently launched Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine), the first and only quadrivalent conjugate vaccine licensed for the prevention of meningococcal disease in Singapore. Menactra® vaccine offers protection against four of the five most common serogroups of the bacterium that cause meningococcal infection, Neisseria meningitidis serogroups [...]

Animal study shows potential of probiotics in protecting against Salmonella infection

A recent animal study shows that oral administration of the probiotic bacterium Lactobacillus casei CRL431 modulates cytokine production and Toll-like receptor (TLR) expression in laboratory mice, thereby improving the animal’s immune response against Salmonella infection. Results of the study were reported in the August issue of the BMC Microbiology journal. The researchers had previously demonstrated [...]

FAO warns against a variant Bird Flu virus strain spreading in Asia

There is a possible major resurgence of the H5N1 highly pathogenic avian influenza, with signs showing that a mutant strain of the Bird Flu virus is spreading in Asia and beyond, warned Food and Agriculture Organization (FAO) of the United Nations. According to the World Health Organization, the H5N1 virus has infected 565 people and [...]

Bayer to support WHO and Stop Tuberculosis Partnership in fighting tuberculosis

Bayer HealthCare is supporting the World Health Organization (WHO) and the Stop Tuberculosis Partnership in fighting multidrugresistant tuberculosis (MDR-TB). Bayer is making 620,000 tablets of the moxifloxacin available to WHO, which will provide the antibiotic to China’s national TB programme through the Stop TB Partnership’s Global Drug Facility. TB causes more than nine million illnesses [...]

GSK and Enigma Diagnostics collaborate on assay development and commercialisation of Enigma’s ML platform

GlaxoSmithKline (GSK) and Enigma Diagnostics Limited recently announced their collaboration on the assay development, commercialisation and supply of the Enigma® ML (mini-lab) system in Europe and other designated countries, including India, Brazil and Russia. Enigma® ML system is Enigma’s first in vitro diagnostic (IVD) instrument that has the potential to deliver raw sample-to-result diagnostic testing [...]

New device offer rapid, cheaper TB diagnosis

In the online August issue of the Journal of Applied Microbiology, researchers report a new method for diagnosing tuberculosis (TB) using a device that measures the heat given off during bacterial growth. The device is faster than the conventional diagnostic methods of growing the bacteria in the lab, and as fast as other more expensive [...]

A*Star scientists combat hospital-acquired infection and bioterrorism toxin

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) discovered a gene that may be a therapeutic target in neutralising the deadly plant toxin Ricin, widely feared for its bioterrorism potential, as well as the Pseudomonas exotoxin (PE) responsible for the tens of thousands of hospital-acquired infections (HAI) in immunocompromised patients worldwide. The research [...]

Majority of hepatitis B carriers not seeking regular monitoring

Despite the potential risk of liver complications that accompany unmanaged hepatitis B, 64 percent of hepatitis B carriers in Singapore are still not seeking regular monitoring to prevent further liver decline.  Thus, in conjunction with World Hepatitis Day 2011, experts are emphasising the need for regular check-ups to prevent and detect further complications of hepatitis [...]

GSK’s drug faces testing in Vietnam

Following the recall of GlaxoSmithKline’s antibiotic Augmentin® (amoxicillin clavulanate) in Hong Kong, the Drug Administration of Vietnam (DAV) is instructing its agencies to collect samples of the drug to test for plasticiser content. The DAV has also requested GSK’s office in Vietnam to work with its distributors to collect Augmentin® samples being sold in the [...]

Multivalent PCV appears to reduce invasive pneumococcal disease

Emerging data is suggesting a declining trend in invasive pneumococcal disease rates, following the introduction of pneumococcal conjugate vaccines (PCV) 10 years ago. “The data we are beginning to see since the introduction of the 13-valent PCV (PCV-13) into our national immunisation programme is also encouraging,” said Dr Catalina Pírez at the press conference of [...]

Copyright © 2012 All rights reserved. Reproduction or redistribution of any content and images, is prohibited without the prior written consent of Ezyhealth Media Pte Ltd.